Dope opera: is nandrolone a medicine or doping agent?

Michael Graham, Peter Evans, Bruce Davies, Non Thomas, Julien Baker

Research output: Contribution to journalArticle

Abstract

The identification of false positive doping tests in sport is pivotal to administering justice to the athlete. Nandrolone is a performance- enhancing drug. Although Nandrolone and its metabolites are on the World Anti-doping Agency list of banned substances, the detection of its abuse may become challenging. Testing positive for Nandrolone is defined as a concentration in the urine exceeding 2 ng·ml-1. It is a strict liability offence. An international athlete tested positive for Nandrolone metabolites in his “A” sample in 2008. The athlete sought immediate legal and medical advice and was advised to exercise his rights of a B sample analysis. There was a variation in levels in A (6.2 ng.ml-1) and B (5.6 ng.ml-1) samples. There are statutory defences which can be argued on legal or medical grounds. One such medical exemption is an application for a therapeutic use exemption certificate, for a legitimate medical condition, to an empowered medical committee before competition. Such exemption allows the sporting participant to use certain specified medical products, but urine and or serum levels of those drugs or its metabolites are required to be within a specified therapeutic range. Problems arise when the therapeutic range is unknown and when there may be co-administration of the same drug in a performance-enhancing design. A recent unique case highlights the difficulties the enforcement agencies have in securing a conviction against a deliberate doping offender versus an accidental doping violation while administering justice and fair-play.
Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalJournal of Exercise Physiology Online
Volume12
Issue number6
Publication statusPublished - 1 Dec 2009

Fingerprint

Nandrolone
Medicine
Athletes
Social Justice
Performance-Enhancing Substances
Substance Abuse Detection
Doping in Sports
Urine
Therapeutic Uses
Pharmaceutical Preparations
Exercise
Therapeutics
Serum

Keywords

  • ergogenic aids
  • anabolic steroids
  • androgens

Cite this

Graham, M., Evans, P., Davies, B., Thomas, N., & Baker, J. (2009). Dope opera: is nandrolone a medicine or doping agent? Journal of Exercise Physiology Online, 12(6), 40-43.
Graham, Michael ; Evans, Peter ; Davies, Bruce ; Thomas, Non ; Baker, Julien. / Dope opera : is nandrolone a medicine or doping agent?. In: Journal of Exercise Physiology Online. 2009 ; Vol. 12, No. 6. pp. 40-43.
@article{bd1ff9fc31f94b80a036c167c29cd244,
title = "Dope opera: is nandrolone a medicine or doping agent?",
abstract = "The identification of false positive doping tests in sport is pivotal to administering justice to the athlete. Nandrolone is a performance- enhancing drug. Although Nandrolone and its metabolites are on the World Anti-doping Agency list of banned substances, the detection of its abuse may become challenging. Testing positive for Nandrolone is defined as a concentration in the urine exceeding 2 ng·ml-1. It is a strict liability offence. An international athlete tested positive for Nandrolone metabolites in his “A” sample in 2008. The athlete sought immediate legal and medical advice and was advised to exercise his rights of a B sample analysis. There was a variation in levels in A (6.2 ng.ml-1) and B (5.6 ng.ml-1) samples. There are statutory defences which can be argued on legal or medical grounds. One such medical exemption is an application for a therapeutic use exemption certificate, for a legitimate medical condition, to an empowered medical committee before competition. Such exemption allows the sporting participant to use certain specified medical products, but urine and or serum levels of those drugs or its metabolites are required to be within a specified therapeutic range. Problems arise when the therapeutic range is unknown and when there may be co-administration of the same drug in a performance-enhancing design. A recent unique case highlights the difficulties the enforcement agencies have in securing a conviction against a deliberate doping offender versus an accidental doping violation while administering justice and fair-play.",
keywords = "ergogenic aids, anabolic steroids, androgens",
author = "Michael Graham and Peter Evans and Bruce Davies and Non Thomas and Julien Baker",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "12",
pages = "40--43",
journal = "Journal of Exercise Physiology Online",
issn = "1097-9751",
publisher = "American Society of Exercise Physiologists",
number = "6",

}

Graham, M, Evans, P, Davies, B, Thomas, N & Baker, J 2009, 'Dope opera: is nandrolone a medicine or doping agent?' Journal of Exercise Physiology Online, vol. 12, no. 6, pp. 40-43.

Dope opera : is nandrolone a medicine or doping agent? / Graham, Michael; Evans, Peter; Davies, Bruce; Thomas, Non; Baker, Julien.

In: Journal of Exercise Physiology Online, Vol. 12, No. 6, 01.12.2009, p. 40-43.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dope opera

T2 - is nandrolone a medicine or doping agent?

AU - Graham, Michael

AU - Evans, Peter

AU - Davies, Bruce

AU - Thomas, Non

AU - Baker, Julien

PY - 2009/12/1

Y1 - 2009/12/1

N2 - The identification of false positive doping tests in sport is pivotal to administering justice to the athlete. Nandrolone is a performance- enhancing drug. Although Nandrolone and its metabolites are on the World Anti-doping Agency list of banned substances, the detection of its abuse may become challenging. Testing positive for Nandrolone is defined as a concentration in the urine exceeding 2 ng·ml-1. It is a strict liability offence. An international athlete tested positive for Nandrolone metabolites in his “A” sample in 2008. The athlete sought immediate legal and medical advice and was advised to exercise his rights of a B sample analysis. There was a variation in levels in A (6.2 ng.ml-1) and B (5.6 ng.ml-1) samples. There are statutory defences which can be argued on legal or medical grounds. One such medical exemption is an application for a therapeutic use exemption certificate, for a legitimate medical condition, to an empowered medical committee before competition. Such exemption allows the sporting participant to use certain specified medical products, but urine and or serum levels of those drugs or its metabolites are required to be within a specified therapeutic range. Problems arise when the therapeutic range is unknown and when there may be co-administration of the same drug in a performance-enhancing design. A recent unique case highlights the difficulties the enforcement agencies have in securing a conviction against a deliberate doping offender versus an accidental doping violation while administering justice and fair-play.

AB - The identification of false positive doping tests in sport is pivotal to administering justice to the athlete. Nandrolone is a performance- enhancing drug. Although Nandrolone and its metabolites are on the World Anti-doping Agency list of banned substances, the detection of its abuse may become challenging. Testing positive for Nandrolone is defined as a concentration in the urine exceeding 2 ng·ml-1. It is a strict liability offence. An international athlete tested positive for Nandrolone metabolites in his “A” sample in 2008. The athlete sought immediate legal and medical advice and was advised to exercise his rights of a B sample analysis. There was a variation in levels in A (6.2 ng.ml-1) and B (5.6 ng.ml-1) samples. There are statutory defences which can be argued on legal or medical grounds. One such medical exemption is an application for a therapeutic use exemption certificate, for a legitimate medical condition, to an empowered medical committee before competition. Such exemption allows the sporting participant to use certain specified medical products, but urine and or serum levels of those drugs or its metabolites are required to be within a specified therapeutic range. Problems arise when the therapeutic range is unknown and when there may be co-administration of the same drug in a performance-enhancing design. A recent unique case highlights the difficulties the enforcement agencies have in securing a conviction against a deliberate doping offender versus an accidental doping violation while administering justice and fair-play.

KW - ergogenic aids

KW - anabolic steroids

KW - androgens

M3 - Article

VL - 12

SP - 40

EP - 43

JO - Journal of Exercise Physiology Online

JF - Journal of Exercise Physiology Online

SN - 1097-9751

IS - 6

ER -